Indeed, weve seen an explosion of potential treatments (oxaloacetate, Rapamycin, nicotine patch, metformin, methylene blue, Abilify, stellate ganglion blocks, plasmapheresis, checkpoint inhibitors, Jak-Stat inhibitors, monoclonal antibodies, neuroplasticity approaches, etc.) since the advent of long COVID
This leads to two undesirable outcomes
It was showed that a GLP-1 analogue with improved half-life in a NEP 24.11 degradation assay had prolonged action in mice, therefore making this assay relevant to evaluate the potential efficacy in vivo of our compounds 40
There is no better solution for delivering the new age of healthcare than a resilient, agile supply chain capable of meeting the on-demand needs of patients, and the exponential growth of GLP-1 drugs over the next several years is sure to test these capabilities
Cravings dropped While this wasnt the main reason I started, it definitely helped me make better food choices more easily